CLEO Diagnostics Ltd (AU:COV) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
CLEO Diagnostics Ltd has updated its corporate governance statement, which is now accessible on their website and reflects full compliance with the ASX Corporate Governance Council’s recommendations for the financial year ended 30 June 2024. The statement, approved by the board and current as of 27 August 2024, provides transparency on the company’s governance practices and adherence to established guidelines.
For further insights into AU:COV stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money